Eruptive squamous cell carcinomas in metastatic melanoma: An unintended consequence of immunotherapy

Samantha Haraszti, Samantha Polly, Harib H. Ezaldein, Robert Rothbaum, Gregory R. Delost*, Mara Beveridge

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)514-517
Number of pages4
JournalJAAD Case Reports
Volume5
Issue number6
DOIs
StatePublished - Jun 2019
Externally publishedYes

Keywords

  • Dynavax
  • SD-101
  • TLR9 agonist
  • checkpoint inhibitor therapy
  • eruptive squamous cell carcinomas
  • immune-related adverse events
  • matrix-metalloproteinase 13
  • metastatic melanoma
  • pembrolizumab

ASJC Scopus subject areas

  • Dermatology

Cite this